Value of MR imaging in differentiating benign from malignant soft-tissue masses: Study of 95 lesions

T. H. Berquist, Richard Lorne Ehman, Bernard Francis King, C. G. Hodgman, D. M. Ilstrup

Research output: Contribution to journalArticle

215 Citations (Scopus)

Abstract

MR imaging has largely replaced CT as the technique of choice for preoperative staging of patients with soft-tissue masses. Whether MR imaging can be used to differentiate benign from malignant masses is controversial. Our experience suggests that MR imaging often can characterize soft-tissue masses accurately. To evaluate this question further, we studied 95 consecutive lesions (50 benign and 45 malignant). Consecutive cases were selected to simulate our clinical practice. Surgical proof was available for all masses except hematomas, for which clinical follow-up confirmed the diagnosis. MR images were interpreted twice by three radiologists. The first review was accomplished without any clinical history and the second review with clinical history. Reviewers were asked to classify the lesion as benign or malignant on the basis of their clinical knowledge and analysis of MR image features (size, lesion margin, signal homogeneity, and neurovascular or bone involvement). Although interpretation varied somewhat because of the experience of the reviewers, the specificity and accuracy of diagnosis averaged 90% for both benign and malignant lesions. Negative predictive value for malignancy averaged 94% among the three reviewers. MR imaging is the technique of choice for identification and characterization of soft-tissue masses. The nature of the lesion (benign vs malignant) can be determined in the majority of cases.

Original languageEnglish (US)
Pages (from-to)1251-1255
Number of pages5
JournalAmerican Journal of Roentgenology
Volume155
Issue number6
StatePublished - 1990

Fingerprint

Hematoma
Bone and Bones
Neoplasms
Radiologists

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Radiological and Ultrasound Technology

Cite this

Value of MR imaging in differentiating benign from malignant soft-tissue masses : Study of 95 lesions. / Berquist, T. H.; Ehman, Richard Lorne; King, Bernard Francis; Hodgman, C. G.; Ilstrup, D. M.

In: American Journal of Roentgenology, Vol. 155, No. 6, 1990, p. 1251-1255.

Research output: Contribution to journalArticle

@article{953c7127d50f4b81a998a677618fd07b,
title = "Value of MR imaging in differentiating benign from malignant soft-tissue masses: Study of 95 lesions",
abstract = "MR imaging has largely replaced CT as the technique of choice for preoperative staging of patients with soft-tissue masses. Whether MR imaging can be used to differentiate benign from malignant masses is controversial. Our experience suggests that MR imaging often can characterize soft-tissue masses accurately. To evaluate this question further, we studied 95 consecutive lesions (50 benign and 45 malignant). Consecutive cases were selected to simulate our clinical practice. Surgical proof was available for all masses except hematomas, for which clinical follow-up confirmed the diagnosis. MR images were interpreted twice by three radiologists. The first review was accomplished without any clinical history and the second review with clinical history. Reviewers were asked to classify the lesion as benign or malignant on the basis of their clinical knowledge and analysis of MR image features (size, lesion margin, signal homogeneity, and neurovascular or bone involvement). Although interpretation varied somewhat because of the experience of the reviewers, the specificity and accuracy of diagnosis averaged 90{\%} for both benign and malignant lesions. Negative predictive value for malignancy averaged 94{\%} among the three reviewers. MR imaging is the technique of choice for identification and characterization of soft-tissue masses. The nature of the lesion (benign vs malignant) can be determined in the majority of cases.",
author = "Berquist, {T. H.} and Ehman, {Richard Lorne} and King, {Bernard Francis} and Hodgman, {C. G.} and Ilstrup, {D. M.}",
year = "1990",
language = "English (US)",
volume = "155",
pages = "1251--1255",
journal = "American Journal of Roentgenology",
issn = "0361-803X",
publisher = "American Roentgen Ray Society",
number = "6",

}

TY - JOUR

T1 - Value of MR imaging in differentiating benign from malignant soft-tissue masses

T2 - Study of 95 lesions

AU - Berquist, T. H.

AU - Ehman, Richard Lorne

AU - King, Bernard Francis

AU - Hodgman, C. G.

AU - Ilstrup, D. M.

PY - 1990

Y1 - 1990

N2 - MR imaging has largely replaced CT as the technique of choice for preoperative staging of patients with soft-tissue masses. Whether MR imaging can be used to differentiate benign from malignant masses is controversial. Our experience suggests that MR imaging often can characterize soft-tissue masses accurately. To evaluate this question further, we studied 95 consecutive lesions (50 benign and 45 malignant). Consecutive cases were selected to simulate our clinical practice. Surgical proof was available for all masses except hematomas, for which clinical follow-up confirmed the diagnosis. MR images were interpreted twice by three radiologists. The first review was accomplished without any clinical history and the second review with clinical history. Reviewers were asked to classify the lesion as benign or malignant on the basis of their clinical knowledge and analysis of MR image features (size, lesion margin, signal homogeneity, and neurovascular or bone involvement). Although interpretation varied somewhat because of the experience of the reviewers, the specificity and accuracy of diagnosis averaged 90% for both benign and malignant lesions. Negative predictive value for malignancy averaged 94% among the three reviewers. MR imaging is the technique of choice for identification and characterization of soft-tissue masses. The nature of the lesion (benign vs malignant) can be determined in the majority of cases.

AB - MR imaging has largely replaced CT as the technique of choice for preoperative staging of patients with soft-tissue masses. Whether MR imaging can be used to differentiate benign from malignant masses is controversial. Our experience suggests that MR imaging often can characterize soft-tissue masses accurately. To evaluate this question further, we studied 95 consecutive lesions (50 benign and 45 malignant). Consecutive cases were selected to simulate our clinical practice. Surgical proof was available for all masses except hematomas, for which clinical follow-up confirmed the diagnosis. MR images were interpreted twice by three radiologists. The first review was accomplished without any clinical history and the second review with clinical history. Reviewers were asked to classify the lesion as benign or malignant on the basis of their clinical knowledge and analysis of MR image features (size, lesion margin, signal homogeneity, and neurovascular or bone involvement). Although interpretation varied somewhat because of the experience of the reviewers, the specificity and accuracy of diagnosis averaged 90% for both benign and malignant lesions. Negative predictive value for malignancy averaged 94% among the three reviewers. MR imaging is the technique of choice for identification and characterization of soft-tissue masses. The nature of the lesion (benign vs malignant) can be determined in the majority of cases.

UR - http://www.scopus.com/inward/record.url?scp=0025678393&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025678393&partnerID=8YFLogxK

M3 - Article

C2 - 2122675

AN - SCOPUS:0025678393

VL - 155

SP - 1251

EP - 1255

JO - American Journal of Roentgenology

JF - American Journal of Roentgenology

SN - 0361-803X

IS - 6

ER -